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The thymus and parathyroid glands in mice develop from a thymus/parathyroid primordium that forms from the endoderm
of the third pharyngeal pouch. We investigated the molecular mechanisms that promote this unique process in which two
distinct organs form from a single primordium, using mice mutant for Hoxa3 and Pax1. Thymic ectopia in Hoxa31/2Pax12/2
compound mutants is due to delayed separation of the thymus/parathyroid primordium from the pharynx. The primordium
is hypoplastic at its formation, and has increased levels of apoptosis. The developing third pouch in Hoxa31/2Pax12/2
compound mutants initiates normal expression of the parathyroid-specific Gcm2 and thymus-specific Foxn1 genes.
owever, Gcm2 expression is reduced at E11.5 in Pax12/2 single mutants, and further reduced or absent in Hoxa31/2Pax12/2
compound mutants. Subsequent to organ-specific differentiation from the shared primordium, both the parathyroids and
thymus developed defects. Parathyroids in compound mutants were smaller at their formation, and absent at later stages.
Parathyroids were also reduced in Pax12/2 mutants, revealing a new function for Pax1 in parathyroid organogenesis. Thymic
ypoplasia at later fetal stages in compound mutants was associated with increased death and decreased proliferation of
hymic epithelial cells. Our results suggest that a Hoxa3–Pax1 genetic pathway is required for both epithelial cell growth
nd differentiation throughout thymus and parathyroid organogenesis. © 2001 Academic Press
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Most of the pharyngeal glandular organs originate from
transient outpocketings of the pharyngeal endoderm called
pharyngeal pouches. The thymus and parathyroid glands in
mice develop from bilateral shared thymus/parathyroid
primordia arising from interactions between the third pha-
ryngeal pouch endoderm and surrounding neural crest cells
(reviewed in Manley, 2000). Although the parathyroid- and
thymus-specific domains in the early primordia are mor-
phologically indistinguishable, each primordium is divided
into organ-specific regions marked by the expression of the
transcription factors Gcm2 and Foxn1, respectively (Gor-
1 Current address: Gene Evaluation and Mapping Laboratory,
USDA Agricultural Research Center, Beltsville, MD 20705.
2 Current address: Department of Biological Sciences, Alabama
tate University, Montgomery, AL 36101-2071.
3 To whom correspondence should be addressed. Fax: (706) 721-
685; E-mail: nmanley@mail.mcg.edu.
316don et al., 2001). Gcm2 and Foxn1 expression in the
primordium predates the morphological separation of para-
thyroid and thymus domains by two full days of develop-
ment. However, the mechanisms controlling the initial
formation of the common primordia and subsequent devel-
opment of the thymus and parathyroids are just beginning
to be understood.
Mutations in several transcription factors including
Hoxa3, Pax1, Pax9, and Foxn1 cause defects in thymus
organogenesis. Hoxa3 is a member of the Hox family of
transcription factors, which specify positional identity in
the developing embryo (Krumlauf, 1994). Hoxa3 homozy-
gous mutants have the most severe thymic defects of the
mutants listed above, as they are athymic and aparathyroid,
and fail to initiate formation of the thymus/parathyroid
primordia (Chisaka and Capecchi, 1991; Manley and Capec-
chi, 1995, 1998; S.E., J. Koushik, J. Gordon, and N.R.M.,
submitted for publication). The closely related paired box
transcription factors Pax1 and Pax9 are also required for
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317Genetic Control of Thymus/Parathyroid Developmentnormal thymus development (Dietrich and Gruss, 1995;
Peters et al., 1998; Wallin et al., 1996). Loss of Pax1
unction results in a hypoplastic thymus that is deficient in
hymocyte development (Dietrich and Gruss, 1995; Wallin
t al., 1996). Loss of Pax9 function results in an early failure
f both thymus and parathyroid organogenesis, although
he exact nature and timing of this phenotype is not yet
lear (Neubu¨ser et al., 1995; Peters et al., 1998). Foxn1
previously whn/Hfh11; Kaestner et al., 2000) is the gene
utated in the classical nude mouse strain, and encodes a
ranscription factor of the winged helix/forkhead class
Nehls et al., 1994). Foxn1 is required cell-autonomously for
thymic epithelial cell differentiation (Blackburn et al.,
1996), but is not required for initiation of thymus organo-
genesis (Nehls et al., 1996). Consistent with this function,
Foxn1 is first expressed in the common primordium after it
forms and is restricted to the more caudal and ventral
portion of the primordium, where it marks the presumptive
thymus-specific region (Gordon et al., 2001).
Less is known about the molecular mechanisms support-
ing parathyroid organogenesis and differentiation. Both
Hoxa3 and Pax9 mutants affect parathyroid development in
combination with other pharyngeal region defects (Chisaka
and Capecchi, 1991; Peters et al., 1998). Recently, Gcm2
has been shown to be specifically required for parathyroid
development (Gunther et al., 2000). One of two mammalian
homologues of the Drosophila gene Glial cells missing,
cm2 encodes a transcription factor with a novel DNA
inding domain (Akiyama et al., 1996; Kim et al., 1998).
Gcm2 mutants have no identifiable parathyroid glands, but
have apparently normal thymus development (Gunther et
al., 2000). Gcm2 expression begins at E9.5 in the caudal
pharyngeal pouches and is progressively restricted to a
small domain within the third pharyngeal pouch endoderm
by E10.5 (Gordon et al., 2001). Within the developing
common thymus/parathyroid primordium, Gcm2 expres-
ion marks the presumptive parathyroid domain in a
omplementary pattern to the thymus marker Foxn1 (Gor-
on et al., 2001), and is subsequently restricted to the
eveloping parathyroid glands (Gunther et al., 2000). Gcm2
xpression is absent in Hoxa32/2 embryos at E10.5, suggest-
ing it may be regulated by Hoxa3 (S.E., J. Koushik, J.
ordon, and N.R.M., submitted for publication).
Our previous studies suggested that there is a functional
ink between Hoxa3 and Pax1 in thymus development
Manley and Capecchi, 1995; Su and Manley, 2000). Hoxa3
nd Pax1 are both expressed in the third pharyngeal pouch
ndoderm, and Pax1 continues to be expressed in thymic
pithelial cells (TECs) throughout thymus development
Manley and Capecchi, 1995; Wallin et al., 1996). Pax1 and
Pax9 are both down regulated in the third pharyngeal pouch
in Hoxa32/2 embryos at embryonic day 10.5 (E10.5) before
morphological differences are present, indicating that they
act downstream of Hoxa3 (Manley and Capecchi, 1995; S.E.,
J. Koushik, J. Gordon, and N.R.M., submitted for publica-
tion). Furthermore, mutations in Hoxa3 and Pax1 have
synergistic effects on thymus development (Su and Manley,
Copyright © 2001 by Academic Press. All right2000). Hoxa31/2Pax11/2 double heterozygotes have a thy-
us phenotype indistinguishable from Pax1 single mu-
ants, indicating a strong genetic interaction between these
wo loci. Hoxa31/2Pax12/2 compound mutant newborns
ave a hypoplastic, ectopic thymus with much more severe
efects in thymocyte development than Pax1 single mu-
ants. Chimera analysis showed that thymocyte develop-
ent defects were due to defective TEC function. These
esults indicate that Hoxa3 and Pax1 (and presumably
ax9) are in a common pathway regulating thymus devel-
pment and TEC differentiation.
In the current study, we investigated the mechanisms
irecting the development of the thymus/parathyroid pri-
ordium and subsequent organogenesis of the thymus and
arathyroid glands using the Hoxa3 and Pax1 mutants. The
hymus/parathyroid primordia in Hoxa31/2Pax12/2 com-
ound mutants form at the correct location and develop-
ental time. However, the primordia are hypoplastic from
heir earliest stage of development and their separation
rom the pharynx is delayed by up to a full day. These
henotypes are associated with a significant increase in
poptosis throughout the thymus/parathyroid primordium
t the initiation of organogenesis. Gcm2 and Foxn1 expres-
ion are both initiated normally in Hoxa31/2Pax12/2 com-
pound mutants, showing that the developing third pouch is
specified correctly into parathyroid and thymus domains
(Gordon et al., 2001). However, Gcm2 expression is reduced
in Pax12/2 single mutants by E11.5, and further reduced or
absent in compound mutants, suggesting that maintenance
of Gcm2 expression and subsequent parathyroid develop-
ment may be dependent on both Hoxa3 and Pax1.
After the common primordium divided into distinct
thymic and parathyroid rudiments at E13.5, the thymic
lobes themselves continued to be hypoplastic and ectopic.
Later, thymic organogenesis defects included increased cell
death and decreased proliferation of TECs at E15.5 as
measured by cell cycle analysis. In addition, Hoxa3 contin-
ues to be expressed in thymic epithelial cells at E15.5 and
even in adult thymus. This expression not only suggests
that TEC defects at later fetal stages are direct effects of the
Hoxa3 and Pax1 mutations, but raises the possibility that
Hoxa3 is involved in adult thymus function. Parathyroid
organogenesis was also abnormal, resulting in initial hyp-
oplasia and subsequent loss of parathyroid glands in com-
pound mutants. Furthermore, we identified a novel defect
in parathyroid development in Pax1 single mutants. Our
results indicate that Hoxa3 and Pax1 act both at the
initiation of thymus/parathyroid organogenesis and
throughout fetal thymus development to regulate thymus
and parathyroid epithelial cell differentiation.
MATERIALS AND METHODS
Mice and Genotyping
The Hoxa3 mutant strain and genotyping by PCR have been
described (Chisaka and Capecchi, 1991; Manley and Capecchi,
s of reproduction in any form reserved.
p318 Su et al.FIG. 1. Three-dimensional reconstructions of E12.5 pharyngeal regions. The pharynx including the esophagus and trachea are shown in
yellow, thymus in blue, and ultimobranchial bodies (UBs) in green. Individual transverse H&E stained sections from the series used to
generate the reconstructions at each of the levels indicated (i–iii) are shown below each reconstruction. (A) Pax12/2 embryo showing normal
haryngeal region development. (B) Hoxa31/2Pax12/2 compound mutant littermate, with normal pharyngeal and UB development, butdelayed separation of the thymic lobes and thymic hypoplasia. The gap in the UB is the result of damage to the sections used in the
reconstruction.
Copyright © 2001 by Academic Press. All rights of reproduction in any form reserved.
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319Genetic Control of Thymus/Parathyroid DevelopmentFIG. 2. Increased cell death in Hoxa31/2Pax12/2 embryos at E12.5. H&E (A, B) and TUNEL (C–H)-stained 6-mm paraffin transverse sections
f E12.5 control (A, C, E) and littermate Pax12/2 (F) and Hoxa31/2Pax12/2 (B, D, G) embryos. (A–B), (C–D), and (E–G) show sections of thymic
lobes from embryos from the same litter. Thymic lobes in each panel are outlined to increase visibility. (A) Wild-type thymic primordium.
(B) Thymic lobe from a littermate Hoxa31/2Pax12/2 embryo, with many apparent apoptotic bodies (arrows). (C, E) Pax11/2 heterozygous
1 2/2 1/2 2/2hymic lobes with few TUNEL cells. (F) Pax1 thymic lobes are similar to controls. (D, G) Hoxa3 Pax1 thymic lobes with very high
levels of apoptosis, much higher than was seen in controls. Scale bar, 75 mm.
Copyright © 2001 by Academic Press. All rights of reproduction in any form reserved.
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320 Su et al.1995). For the Pax1 mutant, we used the Pax1un-ex allele, a deletion
utant that is viable and fertile as a homozygote, and is pheno-
ypically identical to a Pax1-null allele generated by gene targeting
Dietrich and Gruss, 1995; Wallin et al., 1996; Wilm et al., 1998).
Pax1un-ex mice and embryos were also genotyped by PCR as previ-
usly described (Su and Manley, 2000). For simplicity, we will refer
o Pax1un-ex/un-ex mice as Pax12/2. The day of the vaginal plug was
esignated as E0.5. Embryonic stages were confirmed by counting
omites, and by evaluating eye development and limb morphology.
oth mouse strains are maintained as congenic on a C57BL/6
enetic background.
Histology and Three-Dimensional Reconstructions
Embryos were fixed in 4% formaldehyde and paraffin-embedded
by using standard protocols. For three-dimensional reconstruc-
tions, serial sections were cut at 6 mm, stained with hematoxylin
nd eosin, and photographed with a Spot digital camera on an
lympus BX60 microscope. Digital micrographs were aligned and
tructures to be reconstructed were traced in each section by using
dobe Photoshop. The Amira software package (TGS Inc., San
iego, CA) was used to create three-dimensional reconstructions of
he tracings.
TUNEL Assay
Staged embryos were fixed in 4% formaldehyde and processed
for paraffin embedding by using standard techniques. Sections were
cut at 6 mm and stained with hematoxylin and eosin (H&E), or
processed for TUNEL. TUNEL reactions (Gavrieli et al., 1992) were
performed using direct detection of fluorescent nucleotide incor-
poration on paraffin sections. Sections were dewaxed through a
xylene-EtOH series and treated with proteinase K at 10 mg/ml for
5 min at 37°C. Terminal transferase reactions containing 20 mM
tetramethylrhodamine-dUTP, 20 mM dTTP, 1.5 mM CoCl2, 13
dT buffer (BMB), and 1 unit/100 ml TdT (BMB) were performed for
h at 37°C. Sections were washed between steps in phosphate-
uffered saline. Sections were counterstained with DAPI and
ounted in ProLong Anti-Fade reagent (Molecular Probes).
Analysis of TUNEL-stained sections was performed on a Power
acintosh 7600 computer by using the NIH Image program (de-
eloped at the U.S. National Institutes of Health and available on
he Internet at http://rsb.nih.gov/nih-image/). Cell counts and area
easurements were performed on serial sections by using digitized
hotomicrographs of thymic lobes from Hoxa31/2Pax12/2, Pax12/2,
and Pax11/2 E12.5 littermates from two different litters. Compari-
sons were restricted to littermates to control for age differences
between litters. Both lobes from each embryo were analyzed and
each lobe was considered separately. TUNEL-positive cells were
identified and counted with a density slice. At least 90% of
sections from each lobe were measured and counted; sections were
excluded due to tissue damage or if TUNEL staining outside the
thymus in the same section was not detectable. Average numbers
of TUNEL-positive cells and average areas for thymus sections
were compared by using ANOVA analysis.
In Situ Hybridization
Whole-mount in situ hybridizations were performed as described
(Carpenter et al., 1993; Manley and Capecchi, 1995). Probes for
Pax9 (Neubu¨ser et al., 1995), Foxn1, and Gcm2 (Gordon et al.,
2001) were previously described. Digoxigenin-labeled RNA probes
Copyright © 2001 by Academic Press. All rightwere used at 0.5 mg/ml. Alkaline phosphatase-conjugated anti-
digoxigenin Fab fragments were used at 1:5000. BM-purple (Roche/
BMB) was used as a chromagen to localize hybridized probe.
Cytokeratin and Propidium Iodide Staining and
FACS Analysis
Thymic lobes were dissected from E15.5 mouse embryos. Single-
cell suspensions were made by incubating thymic lobes in 1 ml of
0.25% Trypsin/1 mM EDTA at 37°C for 25 min, triturated by
pipetting 10–20 times, then incubated again at 37°C for 5 min, and
a final pipetting 10–20 times. Cells were collected by gentle
centrifugation, then resuspended in a drop (30–50 ml) of PBS with 1
mM EDTA. Cells were fixed by slowly adding 1.5 ml of ice-cold
70% EtOH, then incubating on ice for 1 h. Cells were then rinsed
in PBS and resuspended in staining buffer (2% FCS/PBS/0.05%
NaN3). Cells were stained for 30 min with FITC-conjugated anti-
an cytokeratin antibody (Sigma), then washed with staining buffer
nd PBS. Cells were then incubated with 0.5 ml 50 mg/ml pro-
pidium iodide in PBS and 50 mg/ml RNaseA at 37°C in the dark for
30 min. Data generation and analyses were performed by using a
FACStar Plus flow cytometer with CellQuest software. Significant
differences were determined by the unpaired Student’s t test or
ANOVA analysis.
RT-PCR
RNA was prepared from E15.5–E16.5 day embryonic or adult
thymus, either from whole thymus or from highly enriched thymic
epithelial cells (TECs) prepared by culturing in deoxyguanosine to
remove hematopoetic cells. To isolate TECs, thymic lobes from
E15.5 embryos were isolated and cultured at 37°C in high-oxygen
submersion culture as described previously (Kishi et al., 1995; Su et
l., 1997). Lobes were cultured in 1 ml RPMI medium with 10%
etal bovine serum and 5 3 1025 M 2-mercaptoethamol containing
.35 mM deoxyguanosine (dGuo) for 5 days to deplete thymocytes
and dendritic cells (Jenkinson et al., 1982; Ready and Jenkinson,
1987). Whole or dGuo-treated thymic lobes were homogenized in
TRIzol (Gibco) by using a freshly autoclaved Micro Pellet Pestle
(KONTES) followed by a 5-min incubation at room temperature.
Chloroform was added (1/5 ratio of TRIzol), and samples were
vortexed for 15 s. After a 2- to 3-min incubation at room tempera-
ture, the samples were centrifuged at 12,000g for 15 min at 4°C.
The top phase containing total thymus RNA was harvested into a
fresh tube. The RNA was precipitated using isopropyl alcohol.
Total thymus RNA samples were either left at 270°C in 75%
ethanol or dissolved in 20 ml of DEPC-treated water.
For RT-PCR, genomic DNA was removed from total RNA
reparations by using DNase I. The DNase I enzyme was inacti-
ated using 25 mM EDTA and heated for 15 min at 65°C. Reverse
ranscription was performed by using the GIBCO SuperScript II
ethod. cDNA was subjected to 30 cycles of 94°C (0.5 min), 62°C
1.0 min), and 70°C (1.0 min) using Qiagen PCR Taq polymerase.
ach sample was screened for Hoxa3 and CD45 by using the
ollowing primers: Hoxa3 forward 59-TGCCAGCACAGCCAAG-
GCCCCC-39; Hoxa3 reverse 59-GGCCATCTCCACCCGGC-
CGG-39; CD45 forward 59-TGCTCCTCAAACTTCGACGGA-39;
CD45 reverse 59-CTGCCAAAAGTCACCGATCGT-39. These prim-
ers generate predicted products of 254 bp for Hoxa3 and 655 bp for
CD45. Primers for both Hoxa3 and CD45 cross an intron, and the
specificity of the PCR products were confirmed by sequencing.
s of reproduction in any form reserved.
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321Genetic Control of Thymus/Parathyroid Developmentb-actin primers generating a 91-bp product were previously described
(Mansour et al., 1993).
RESULTS
Delayed Separation of the Thymus/Parathyroid
Primordium in Compound Mutants
We used histological analysis and three-dimensional re-
constructions to determine the time course and morpho-
logical characteristics of pharyngeal organ development.
The thymus and parathyroids in mice originate from shared
bilateral thymus/parathyroid primordia that develop from
the third pharyngeal pouches. At E11.5, the thymus/
parathyroid primordia have formed but are still attached to
the pharyngeal endoderm (data not shown). By E12.5, the
thymus/parathyroid primordia (in blue) and the ultimo-
branchial bodies (UBs; in green) that form from the fourth
pouch had separated completely from the pharynx in both
controls and Pax1 single mutants (Fig. 1A). The thymus/
parathyroid primordia had begun their migration toward
the anterior thoracic cavity (Fig. 1A). At this stage, the
organ primordia in Pax12/2 mutants were similar in size and
ocation to controls; Pax12/2 mutants were not significantly
ifferent from controls until after E13.5 (data not shown).
In contrast, defects were apparent in Hoxa31/2Pax12/2
compound mutants as early as E11.5, just after the thymus/
parathyroid primordia form. Even at this early stage, the
Hoxa31/2Pax12/2 mutant primordia were already smaller
than in controls (not shown). At E12.5, the organ primordia
in Hoxa31/2Pax12/2 embryos remained smaller than in
controls and Pax1 single mutants. In some cases, one or
both primordia were still attached to the pharynx, although
the pharynx and trachea (in yellow) and UBs appeared
normal (Fig. 1B). These results suggested that the thymic
ectopia seen at E17.5 in Hoxa31/2Pax12/2 compound mu-
ants (Su and Manley, 2000) is most likely caused by
elayed separation of the thymic/parathyroid primordium
rom the pharyngeal pouch. The phenotype in the com-
ound mutants was variable, but always more severe than
hat of Pax1 single mutants. We also noted that cysts which
are apparent in the thymic lobes of both Pax1 single
mutants (Wallin et al., 1996) and Hoxa31/2Pax12/2 com-
ound mutants (Su and Manley, 2000) are not seen early in
rganogenesis, but develop after E14.5 (not shown), and
herefore may be a secondary consequence of abnormal
pithelial cell differentiation.
Increased Cell Death at Early Stages of
Organogenesis in Compound Mutants
The histological analysis showed that the thymus/
parathyroid primordia in Hoxa31/2Pax12/2 embryos are hy-
poplastic from a very early stage. A possible reason for this
hypoplasia was seen by closer inspection of the H&E-
stained sections. In all seven Hoxa31/2Pax12/2 E12–12.5
mbryos examined, there was evidence of higher levels of i
Copyright © 2001 by Academic Press. All rightpoptosis than in controls (Figs. 2A and 2B). Condensed and
ragmented nuclei were seen throughout both common
rimordia of Hoxa31/2Pax12/2 embryos at this stage (Fig.
2B). TUNEL staining of three additional E12.5 Hoxa31/2-
Pax12/2 embryos and three Pax11/2 littermate controls
confirmed that these represented apoptotic cells, and that
these cells were more numerous in compound mutants
(Figs. 2D and 2G) than in controls (Figs. 2C and 2E). Pax12/2
littermates were identical to heterozygous controls (Fig.
2F), indicating that this phenotype was specific to com-
pound mutants. Quantitation of the percentage of TUNEL-
positive cells in Hoxa31/2Pax12/2 thymic lobes at E12.5
showed a significant increase of 2- to 6-fold relative to
Pax11/2 and Pax12/2 littermates (P , 0.05). Since increased
apoptosis was seen throughout the common thymus/
parathyroid primordia, it could provide a mechanism for
both thymus and parathyroid hypoplasia in the compound
mutants.
Gcm2 and Foxn1 Expression in Pax1 Single
Mutants and Hoxa3-Pax1 Compound Mutants
To investigate potential molecular mechanisms underly-
ing the observed morphological changes in the thymus/
parathyroid primordia, we examined the expression of
Foxn1 and Gcm2. Foxn1 and Gcm2 are required for thymus
nd parathyroid differentiation, respectively (Gunther et
l., 2000; Nehls et al., 1996), and their expression patterns
refigure division of the shared primordium into distinct
hymus and parathyroid organ rudiments (Gordon et al.,
001). Changes in the expression of these genes before the
ppearance of overt phenotypes could provide a possible
echanism for the observed defects. Foxn1 was expressed
n the presumptive thymus-specific region of the thymus/
arathyroid primordia at E11.5 in control, Pax12/2, and
Hoxa31/2Pax12/2 compound mutant embryos (Fig. 3A).
Both the timing and location of Foxn1 gene expression
appear normal. Gcm2 expression also appeared normal in
he third pouch of both control and Hoxa31/2Pax12/2 com-
ound mutants at E10.5 (Figs. 3B and 3C). However, by
11.5, Gcm2 expression was variably but consistently re-
duced in Pax1 single mutant embryos (Fig. 3E) compared to
control embryos (Fig. 3D). Furthermore, in Hoxa31/2Pax12/2
compound mutants, Gcm2 expression was reduced even
further or absent (compare Fig. 3F with 3G). This loss was
striking in contrast to the relatively normal expression of
Foxn1 at this stage (Fig. 3A). These results show that the
developing third pouch is initially designated correctly into
parathyroid and thymus-specific domains, and that thymic
epithelial cell fate is appropriately specified, in both Pax12/2
single and Hoxa31/2Pax12/2 compound mutants. However,
arathyroid development is specifically impaired within
he common thymus/parathyroid primordium as early as
11.5. This impairment is seen in Pax1 single mutants, ands exacerbated in Hoxa31/2Pax12/2 compound mutants.
s of reproduction in any form reserved.
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322 Su et al.Multiple Organogenesis Defects in Compound
Mutants at E13.5
By E13.5 in controls, the thymus (blue) and parathyroids
(red) were easily identifiable as separate structures (Fig. 4A).
The thymic lobes had increased in size and migrated
substantially, with the most caudal point near the final
adult position of the thymus (Fig. 4A, ii). At E13.5, the
primordia in the Hoxa31/2Pax12/2 mutants had all sepa-
rated from the pharynx, and most had divided into distinct
thymus and parathyroid rudiments (Figs. 4B and 4C). How-
ever, mild to severe defects were seen in the parathyroids,
ultimobranchial bodies, and thymus at this stage.
Parathyroid Defects in Pax12/2 and Hoxa31/2Pax12/2
Mutants
Parathyroid primordia (red) in compound mutants at
FIG. 3. Expression of organ-specific marker genes in Pax12/2 and
of E10.5 (B, C) or hemisected E11.5 (A, D–G) embryos. Identity of p
below the embryos. (A) Foxn1 expression is relatively normal in bo
B, C) Gcm2 expression at E10.5 is identical in controls (B) and Hox
s noticably reduced in Pax12/2 embryos (E) relative to litterm
Hoxa31/2Pax12/2 compound mutants (G) relative to littermate conE13.5 were smaller than in controls, and were not always s
Copyright © 2001 by Academic Press. All rightdentifiable (Fig. 4B). To further investigate this phenotype,
e looked for parathyroid glands in control, Pax11/2, and
oxa31/2Pax12/2 compound mutants at the newborn stage.
Both parathyroid glands were easily found in wild-type and
Hoxa3 heterozygous mice (Figs. 5A and 5B, and not shown).
In contrast, the parathyroids in Pax12/2 newborns were
everely hypoplastic, although they were readily identified
n all five E17.5 Pax12/2 embryos examined (Figs. 5C and
D). Parathyroids in Pax12/2 newborns had estimated vol-
umes that were approximately 6- to 8-fold smaller than
controls. In contrast, no identifiable parathyroids were seen
in four out of five E17.5 Hoxa31/2Pax12/2 compound mu-
ants. In the one remaining E17.5 compound mutant, a
ingle epithelial structure that may have been a parathyroid
emnant was seen next to the thymus; however, it had an
bnormal, follicle-like epithelial cell structure (Figs. 5E and
F). The presence of parathyroid rudiments at E13.5 (Fig. 4)
31/2Pax12/2 embryos. Whole mount in situ hybridization analysis
used is indicated in the upper left corner, genotypes are indicated
ax12/2 and Hoxa31/2Pax12/2 compound mutant embryos at E11.5.
Pax12/2 compound mutants (C). (D, E) By E11.5, Gcm2 expression
controls (D). (F, G) This reduction is even more dramatic in
(F).Hoxa
robes
th P
a31/2howed that this phenotype was not due to failure of initial
s of reproduction in any form reserved.
323Genetic Control of Thymus/Parathyroid DevelopmentFIG. 4. Three-dimensional reconstructions of E13.5 pharyngeal regions from one control (A) and two littermate compound mutants (B, C).
The esophagus and trachea are shown in yellow, thymus in blue, ultimobranchial bodies (UBs) in green, parathyroids in red, and thyroid
in purple. Individual transverse H&E stained sections from the series used to generate the reconstructions at each of the levels indicated
(i–iii) are shown below each reconstruction. (A) Wild-type control. Both parathyroids are identifiable, with one still closely contacting the
thymus. The UBs have initiated fusion with the thyroid gland, and are therefore not shown in a separate color. (B) Hoxa31/2Pax12/2
compound mutant with a single hypoplastic parathyroid and unfused UBs. Both thymic lobes are smaller than control and have not yet
reached the anterior thoracic cavity (B, iii). (C) A second Hoxa31/2Pax12/2 compound mutant from the same litter has a less severe
phenotype. Both parathyroids are present although small, and one of the thymic lobes is located further posterior. The UBs have not yet
fused with the thyroid, although they are closely associated with it.
Copyright © 2001 by Academic Press. All rights of reproduction in any form reserved.
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324 Su et al.parathyroid rudiment formation from the thymus/
parathyroid primordium. Of three Hoxa31/2Pax12/2 com-
ound mutants examined at E13.5, two had either one (Fig.
B) or two (Fig. 4C) parathyroids that were clearly hypoplas-
ic, while the remaining one had no identifiable parathy-
oids. These data show that Hoxa3 and Pax1 mutations had
rofound and synergistic effects on parathyroid organogen-
sis, and are consistent with the Gcm2 expression patterns
n these mutants.
Ultimobranchial Body Development Is Relatively
Normal in Compound Mutants
UBs develop from the fourth pharyngeal pouch and fuse
with the dorsal and anterior aspect of the main body of the
thyroid gland, and subsequently form the calcitonin-
producing C cells in the thyroid (Moseley et al., 1968).
Hoxa3 mutants have defects in UB development, and some-
imes lack UB-derived C cells (Manley and Capecchi, 1995),
lthough early UB organogenesis is normal (S.E., J. Koushik,
. Gordon, and N.R.M., submitted for publication). The UBs
n our reconstructed E13.5 control embryos had already
used to the thyroid, and are no longer visible as distinct
tructures (Fig. 4A). In contrast to the thymus and parathy-
oid phenotypes in Hoxa31/2Pax12/2 compound mutants,
ultimobranchial body development appeared relatively nor-
mal, although there was a slight delay in the fusion of the
UBs to the thyroid proper (Figs. 4B and 4C). Ectopic or
persistent UBs were never seen at later stages in Hoxa31/2-
Pax12/2 compound mutants.
Defects in Thymus Organogenesis at E13.5 in
Compound Mutants
After the thymic lobes in Hoxa31/2Pax12/2 compound
mutants separated from the thymus/parathyroid primordia
at E13.5, they remained smaller than controls throughout
the remainder of fetal development (Figs. 4B and 4C; Su and
Manley, 2000). Although they had begun their caudal mi-
gration, most thymic lobes at this stage had not yet reached
the anterior thoracic cavity (Figs. 4B, iii and 4C, iii).
Comparison of external morphology (including limb and
tail morphology, eye pigmentation, and overall embryonic
size) and embryonic body weights at E12.5, E15.5, and E17.5
showed no differences between genotypes (not shown).
Therefore, the observed phenotypes in the thymus size and
migration were not due to a general developmental retarda-
tion.
Changes in TEC Death and Proliferation at E15.5
in Compound Mutants
The observed thymic hypoplasia in compound mutants at
E13.5 either was due to a continuing defect in TEC devel-
opment, or was a consequence of the earlier defects at
initial primordium formation. To distinguish between
these possibilities, we performed a cell cycle analysis of
Copyright © 2001 by Academic Press. All rightreshly isolated E15.5 cytokeratin-positive TEC stained
ith propidium iodide by flow cytometry (Figs. 6A–6C).
oxa31/2Pax12/2 compound mutants had significant
changes in the frequencies of both cell death and prolifera-
tion in TECs relative to control and Pax12/2 mutants at
15.5. Cell death was increased approximately 4-fold (P ,
.01; Fig. 6D), while the percentage of proliferating cells
as decreased by 30% (P , 0.05; FIg. 6E). This result shows
hat both the survival and growth of TECs in Hoxa31/2-
ax12/2 compound mutants continued to be affected at later
tages of fetal development.
Hoxa3 Is Expressed in TECs throughout Thymus
Organogenesis
The changes in TEC proliferation and cell death at E15.5
suggested that the Hoxa3 and Pax1 mutations were having
a direct effect on later TEC development. Pax1 is expressed
both in the pharyngeal endoderm and in TECs through
mid-gestation (Wallin et al., 1996). Hoxa3 is expressed in
the pharyngeal pouch endoderm at the initiation of thymus
organogenesis (Manley and Capecchi, 1995). However,
Hoxa3 has not been shown to be expressed in the develop-
ing thymus at later fetal stages. We used RT-PCR to show
that Hoxa3 is expressed in TECs at E15.5 (Fig. 7). TECs
were prepared by deoxyguanosine treatment of E15.5 fetal
thymic lobes (Jenkinson et al., 1982; Ready and Jenkinson,
1987). This treatment resulted in a dramatic reduction in
hematopoietic cells, confirmed by reduced expression of the
hematopoetic-specific marker CD45 (Fig. 7). These results
suggest that Hoxa3 continues to play a role in TEC devel-
opment beyond the initiation of organogenesis, and that the
defects in Hoxa31/2Pax12/2 compound mutants at E15.5
ould be direct effects, rather than secondary effects of an
arlier phenotype. To our surprise, Hoxa3 expression was
lso seen in adult thymus RNA (Fig. 7). This later expres-
ion implicates Hoxa3 in mature thymus function, as well
s in fetal thymus development.
DISCUSSION
The development of the thymus and parathyroids from
the third pharyngeal pouch represents a unique program of
organogenesis. Our results provide evidence that the mo-
lecular mechanisms directing this process, as well as those
required for later thymus and parathyroid growth and
differentiation, depend on the functions of the same set of
transcription factors, including Hoxa3 and Pax1. Mutations
n Hoxa3 and Pax1 have synergistic effects on the develop-
ent of these organs, suggesting that they are in a common
enetic pathway. We have previously shown that Hoxa31/2-
Pax12/2 compound mutants at E17.5 had ectopic, cystic,
and hypoplastic thymic lobes (Su and Manley, 2000). In the
current study, we provide evidence for important functions
for this pathway from the earliest stages of organogenesis
throughout fetal development.
s of reproduction in any form reserved.
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325Genetic Control of Thymus/Parathyroid DevelopmentOur data indicate that the thymic ectopia in Hoxa31/2-
Pax12/2 compound mutants is caused primarily by delayed
separation from the pharynx. These results suggest that the
problem is not a defect in organ primordia migration per se,
but a result of delayed separation of the primordium from
the pharynx. By the time this separation has occurred, the
environment through which the developing primordium
must migrate has developed further, causing variable envi-
ronmental delays or blocks in descent as a secondary effect.
Another possibility is that the ectopia is a secondary effect
of hypoplasia. However, other mutants that have small
thymuses do not have ectopic thymic lobes, the nude
mouse being the best example (Cordier and Haumont, 1980;
Schorpp et al., 2000). Also, the phenotype in the compound
mutants is variable, and the ectopia does not strictly
correlate with the degree of hypoplasia. Therefore, the
weight of evidence suggests that delayed separation from
the pharynx is the primary cause of ectopia in the com-
pound mutants. This conclusion is consistent with a model
in which separation of the thymus/parathyroid primordium
from the pharynx is independent of proliferation and
growth of the rudiment, and that Hox and Pax genes control
both of these processes.
The thymic hypoplasia seen in the compound mutants is
caused by increased epithelial cell death throughout fetal
thymus development, combined with decreased epithelial
proliferation. Mutations in Hox genes have been associated
with elevated apoptosis in the hindbrain in Hoxa12/2 and
oxa12/2Hoxa22/2 mutants, although proliferation was un-
affected (Barrow et al., 2000; Rossel and Capecchi, 1999).
Differences in proliferation have also been proposed as a
mechanism for Hox gene patterning in the limbs and in
cervical vertebrae (Condie and Capecchi, 1993; Davis et al.,
1995; Duboule, 1995; Goff and Tabin, 1997). Expression of
Hox genes has been linked to regulating the balance of
proliferation and differentiation, either by inhibiting prolif-
eration to induce differentiation (Bromleigh and Freedman,
2000), or promoting proliferation at the expense of differen-
tiation (Salser and Kenyon, 1996; Sauvageau et al., 1995,
1997). Pax1 has also been shown to control proliferation;
double mutants for Pax1 and Pax9 have also been shown to
have decreased proliferation and increased apoptosis in the
developing sclerotome (Peters et al., 1999). In the case of
thymus and parathyroid development, Hoxa3 and Pax1
would seem to promote proliferation, survival, and differ-
entiation in the developing primordium. Since Foxn1 ex-
pression appears relatively normal in the compound mu-
tants, the affect on apoptosis and proliferation may be
independent of effects on differentiation, at least at the
level of specifying the thymic primordium.
We have previously shown that Hoxa31/2Pax12/2 com-
ound mutants have defects in TEC differentiation that
esult in an inability to promote normal thymocyte matu-
ation (Su and Manley, 2000). Effects on TEC development
ncluded a significant reduction in total TEC number,
educed numbers of MHC class II1 TECs, and reduced levelof MHC class II expression. The current study provides s
Copyright © 2001 by Academic Press. All rightevidence that the reduction in TEC number in compound
mutants is the result of both increased apoptosis and
decreased proliferation of epithelial cells. Effects are seen at
both initial organogenesis and at later fetal stages. Since
both Hoxa3 (this report) and Pax1 (Wallin et al., 1996) are
expressed throughout fetal thymus development, both the
early and later phenotypes could be direct effects of these
mutations.
We were unable to detect a defect in TEC proliferation or
apoptosis in the Pax1 single mutants in this study. The lack
of a phenotype in the Pax1 single mutants in this assay is
also consistent with our previous results showing normal
numbers of TECs in Pax12/2 mutants (Su and Manley,
2000). Taken together, these results show that the thymic
hypoplasia in Pax12/2 mice is largely or entirely due to
reduced numbers of thymocytes. This result is also consis-
tent with the relatively normal early development of the
thymus in Pax1 mutants, since thymocytes are not numer-
ous in the thymus until about E13.5. As we have also
shown that hematopoietic cells in these mice are normal
(Su and Manley, 2000), the reduced numbers of thymocytes
reflect reduced TEC function. Therefore, the Pax1 mutation
lone primarily affects TEC differentiation, rather than
rganogenesis. The role of Pax1 in thymus organogenesis is
hus only revealed in combination with mutation of Hoxa3.
The relative mildness of the Pax12/2 thymus phenotype is
strong contrast to the severity of the parathyroid pheno-
ype in Pax1 single mutants. We also found evidence for a
ink between Hoxa3 and Pax1 in parathyroid development.
Both Pax1 (this report) and Hoxa3 (Chisaka and Capecchi,
991; Kovacs et al., 2001) single mutants have parathyroid
efects, and in Hoxa31/2Pax12/2 compound mutants para-
thyroid glands are apparently absent. The importance of
Pax1 in parathyroid development is consistent with the
expression of Pax1 in the common thymus/parathyroid
primordium (Wallin et al., 1996), and with the defective
parathyroid development in Pax9 homozygous mutants
(Peters et al., 1998). Hoxa3 has an even more important role
in parathyroid development, as it is required for initiation
of parathyroid organogenesis (Chisaka and Capecchi, 1991;
S.E., J. Koushik, J. Gordon, and N.R.M., submitted for
publication). In addition, Hoxa3 heterozygotes have a de-
crease in serum PTH levels (Kovacs et al., 2001), although
the parathyroids are normal sized. This result indicates that
Hoxa3 is haploinsufficient for parathyroid differentiation
and/or function.
The parathyroid defects in both Pax12/2 single mutants
nd Hoxa31/2Pax12/2 compound mutants may be mediated
through Gcm2. Gcm2 mutants have a profound defect in
arathyroid gland development (Gunther et al., 2000), and
Gcm2 expression is lost prior to primordium formation in
Hoxa3 single mutants (S.E., J. Koushik, J. Gordon, and
N.R.M., submitted for publication). In both Pax12/2 single
mutants and Hoxa31/2Pax12/2 compound mutants, Gcm2
xpression is initiated normally but then downregulated at
ormation of the common primordium. This effect is more
evere in compound mutants than in Pax12/2 single mu-
s of reproduction in any form reserved.
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326 Su et al.tants. These results suggest that Hoxa3 is required for
initial Gcm2 expression, but both Hoxa3 and Pax1 are
required for maintenance of Gcm2. Reconstructions show a
variable failure of parathyroid formation from the common
primordium, and no identifiable parathyroids were present
at later embryonic stages. These results suggest that the
failure to maintain Gcm2 expression in Hoxa31/2Pax12/2
compound mutants may ultimately result in failure of
parathyroid development. It is not known whether Gcm2
xpression is required for survival of parathyroid cells. The
ack of increased cell death in the E12.5 shared rudiment in
ax12/2 mutants suggests that the loss of parathyroids is
FIG. 5. Parathyroid defects in Pax12/2 and Hoxa31/2Pax12/2 muta
re higher magnifications of sections shown in (A), (C), and (E). (
Pax12/2 single mutant with severe parathyroid hypolasia. (E, F) Ho
No other compound mutants analyzed had any identifiable parathy
E, 200 mm; in B, D, F, 50 mm.ot due to apoptosis of parathyroid precursors in these s
Copyright © 2001 by Academic Press. All rightutants, although it could be involved in the compound
utant phenotype. Further analysis of the Gcm2 mutants
ill be needed to provide definitive evidence for a causal
ink between these two phenotypes.
Alternatively, apoptosis of the parathyroid precursors in
oxa31/2Pax12/2 compound mutants could be independent
f loss of Gcm2 expression. This possibility is supported by
he delay of up to 2 days between loss of Gcm2 expression
nd failure of parathyroid development, by the fact that
poptosis is seen throughout the thymus/parathyroid pri-
ordium, and by the relatively normal Foxn1 expression at
he same stage that Gcm2 is lost. Elegant and detailed
t E17.5. H&E-stained transverse paraffin sections. (B), (D), and (E)
Hoxa31/2 control with normal parathyroid development. (C, D)
/2Pax12/2 compound mutant with a possible parathyroid remnant.
tissue. pt, parathyroid; ty, thyroid; th, thymus. Scale bars in A, C,nts a
A, B)
xa31tudies of homeobox gene function in both Drosophila
s of reproduction in any form reserved.
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327Genetic Control of Thymus/Parathyroid Development(Weatherbee et al., 1998) and Caenorhabditis elegans
(Salser and Kenyon, 1996) have provided evidence that Hox
genes may act at multiple points within the development of
a cell type or structure, regulating cell death, proliferation,
and differentiation at different points along a developmen-
tal pathway. Hoxa3 could be playing a similar role in
parathyroid and thymus development, promoting initial
formation of the common primordium, expression of differ-
entiation markers, and regulating apoptosis and prolifera-
tion at different times within the developing primordium.
Our data provide new information about the structure of
the genetic pathway for parathyroid and thymus organogen-
esis, and the role of Hoxa3 and Pax1 during embryonic
evelopment. The Hoxa3 homozygous mutant fails to ini-
iate formation of the thymus/parathyroid primordium
S.E., J. Koushik, J. Gordon, and N.R.M., submitted for
ublication), preventing analysis of later roles for Hoxa3 in
hymus and parathyroid development. The compound mu-
ant analysis described here, combined with the expression
FIG. 6. Cell cycle analysis of thymic epithelial cells (TECs) by FAC
with a pan-cytokeratin antibody and propidium iodide for cell cycl
the cytokeratin-positive gate (R). (C) Cell cycle analysis of the cytok
the percentage of apoptotic cells (,2N, M1) and proliferating cell
oxa31/2Pax12/2 compound mutants have an average level of apop
in the M2 (S 1 G2M) population. Hoxa31/2Pax12/2 compound mut
in (D) and (E) indicate significant differences (P , 0.05) by Anova
each genotype; data is shown as the average value 6 SEM.f Hoxa3 in the developing thymus, provides evidence for H
Copyright © 2001 by Academic Press. All rightuch a later role, at least during fetal stages. Similarly, our
ata shows that the thymus defect in Pax1 single mutants
s primarily in TEC differentiation, with a role in thymus
rganogenesis revealed only in combination with the
oxa3 mutation. However, the normal expression of Foxn1
n the compound mutants shows that specification of the
EC lineage is unaffected. This result is consistent with the
ack of a genetic interaction between Hoxa3 and Foxn1
A.N., C. Raines, J. Chen, and N.R.M., unpublished data),
nd is consistent with there being at least two separate
athways controlling fetal TEC differentiation. Further-
ore, the expression of Hoxa3 in the adult thymus raises
he intriguing possibility that Hoxa3 may continue to
unction in the thymus beyond fetal stages.
In contrast, there is so far evidence for only a single
athway for parathyroid development, which includes
oxa3, Pax1/9, and Gcm2. Both initiation and mainte-
ance of Gcm2 expression appear to be under the control of
his pathway. There is also evidence for a separate role for
ingle-cell suspensions from whole E15.5 thymic lobes were stained
lysis. (A, B) Control genotype showing the parameters used to set
n-positive gated population (R), showing the gates used to measure
G2M, M2). (D) Percentage of cells in the M1 (,2N) population.
epithelial cells 5-fold higher than controls. (E) Percentage of cells
have a 30% decrease in proliferating epithelial cells. Asterisks (*)
sis. Each bar represents data from at least 10 separate embryos ofS. S
e ana
erati
s (S 1
totic
ants
analyoxa3 in the differentiation or function of PTH-producing
s of reproduction in any form reserved.
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328 Su et al.cells (Kovacs et al., 2001), independent of Gcm2. Taken
together, these results provide evidence for multiple roles
for Hoxa3 during fetal thymus and parathyroid organogen-
esis and differentiation, and in mature organ function.
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